CSBR:NASDAQ
Champions Oncology Inc
4,59 USD
arrow_downward
−1,89%(−0,088) 1 D
17. nov., 15:41:49 GMT-5 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for CSBR …
Åpne
4,70 USD
Høy
4,70 USD
Lav
4,59 USD
Markedsverdi
63,91 mill.
Snittvolum
7,80k
Volum
4,38k
52 u høy
8,31 USD
52 u lav
4,52 USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92 mill.
Antall ansatte
217
Åpne
4,70 USD
Høy
4,70 USD
Lav
4,59 USD
Markedsverdi
63,91 mill.
Snittvolum
7,80k
Volum
4,38k
52 u høy
8,31 USD
52 u lav
4,52 USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92 mill.
Antall ansatte
217
Nyhetssaker
Fra nettkilder og nyhetspartnere
ChartMill
·
for 51 minutter siden
S&P 500 Losers: Software Stocks Lead Session Declines
Fox Business
·
for 1 time siden
S&P 500 decline driven by semiconductor confidence issues, says Scott Chronert
MarketWatch
·
for 41 minutter siden
Only two ‘Magnificent Seven’ stocks have managed to beat the S&P 500 since the start of 2025
Traders Union
·
for 1 time siden
Bitcoin-to-S&P 500 ratio holds trendline support, James Van Straten notes
Profil
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
Om Champions Oncology Inc
Administrerende direktør-
Ansatte217
Grunnlagt2007
HovedkontorHackensack, New Jersey, USA
SektorHealth Care
Bransje-
Nettstedchampionsoncology.com